Women's Knowledge of Contraception During the Postpartum Period (CO CT-PP)

February 23, 2026 updated by: Université de Reims Champagne-Ardenne

In France, the number of unintended or unwanted pregnancies remains a public health issue, often leading to voluntary termination of pregnancy. This issue is, moreover, one of the priorities of the national sexual health strategy launched by the Ministry of Social Affairs and Health for the period from 2017 to 2030.

The postpartum period (ranging from 0 to 24 months) is recognized as a high-risk period for unplanned pregnancies, which may result in voluntary termination of pregnancy. This observation raises questions about the effectiveness of prevention and information policies regarding postpartum fertility and the various contraceptive methods.

Better information and the use of regular contraception, or recourse to emergency contraception, could help reduce the number of unwanted pregnancies during the postpartum period.

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Detailed Description

The primary objective is to describe women's knowledge regarding contraception in the postpartum period, particularly emergency contraception

Study Type

Observational

Enrollment (Actual)

1000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Reims, France, 51100
        • Ufr Medecine Urca

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Adult women in the postpartum period (defined as up to 24 months after delivery)

Description

Inclusion Criteria:

  • Adult women
  • Between 0 and 24 months postpartum
  • agreeing to participate in the study

Exclusion Criteria:

  • Minors
  • Having given birth more than 2 years ago
  • Legally protected (guardianship, curatorship, judicial protection)
  • Not agreeing to respond to the questionnaire

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Questionnaire on knowledge regarding contraception
Time Frame: Day 0
Women's knowledge regarding contraception in the postpartum period (0-24 months after childbirth) assessed by a questionnaire developed by a working group composed of midwives, methodologists and a data manager. The questions will address the different contraceptive methods and their possible use in the postpartum period, as well as knowledge concerning the risk of pregnancy during the postpartum period.
Day 0

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Université de Reims Champagne-Ardenne

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 18, 2025

Primary Completion (Actual)

December 18, 2025

Study Completion (Estimated)

June 1, 2026

Study Registration Dates

First Submitted

February 12, 2026

First Submitted That Met QC Criteria

February 23, 2026

First Posted (Actual)

February 27, 2026

Study Record Updates

Last Update Posted (Actual)

February 27, 2026

Last Update Submitted That Met QC Criteria

February 23, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2025_RIPH_16_SF_A Odent

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Contraception

Clinical Trials on data collection

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Panama

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe